Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist

The Journal of Pharmacology and Experimental Therapeutics
David J NichollsCarina Kärrman Mårdh

Abstract

In normal physiologic responses to injury and infection, inflammatory cells enter tissue and sites of inflammation through a chemotactic process regulated by several families of proteins, including inflammatory chemokines, a family of small inducible cytokines. In neutrophils, chemokines chemokine (CXC motif) ligand 1 (CXCL1) and CXCL8 are potent chemoattractants and activate G protein-coupled receptors CXC chemokine receptor 1 (CXCR1) and CXCR2. Several small-molecule antagonists of CXCR2 have been developed to inhibit the inflammatory responses mediated by this receptor. Here, we present the data describing the pharmacology of AZD5069 [N-(2-(2,3-difluorobenzylthio)-6-((2R,3S)-3,4-dihydroxybutan-2-yloxy)[2,4,5,6-(13)C4, 1,3-(15)N2]pyrimidin-4-yl)azetidine-1-sulfonamide,[(15)N2,(13)C4]N-(2-(2,3-difluoro-6-[3H]-benzylthio)-6-((2R,3S)-3,4-dihydroxybutan-2-yloxy)pyrimidin-4-yl)azetidine-1-sulfonamide], a novel antagonist of CXCR2. AZD5069 was shown to inhibit binding of radiolabeled CXCL8 to human CXCR2 with a pIC50 value of 9.1. Furthermore, AZD5069 inhibited neutrophil chemotaxis, with a pA2 of approximately 9.6, and adhesion molecule expression, with a pA2 of 6.9, in response to CXCL1. AZD5069 was a slowly reversible antagonist...Continue Reading

References

Oct 11, 1990·The New England Journal of Medicine·J BousquetP Godard
Nov 1, 1993·The American Review of Respiratory Disease·M LindenR Brattsand
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·S A JonesM Baggiolini
Mar 2, 2002·The European Respiratory Journal·I SabroeJ E Pease
Apr 18, 2002·The American Journal of Medicine·Stuart A LittleNeil C Thomson
Oct 24, 2002·Critical Care Medicine·Anna KurdowskaSeamas C Donnelly
Mar 6, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Naofumi Mukaida
Nov 18, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Lee J QuintonGregory J Bagby
May 25, 2004·Journal of Leukocyte Biology·Suzanne L TravesLouise E Donnelly
Jun 25, 2004·The New England Journal of Medicine·James C HoggPeter D Paré
Jul 5, 2005·Thorax·A V KamathE R Chilvers
Feb 18, 2006·The Journal of Clinical Investigation·Jörg ReutershanKlaus Ley
Mar 14, 2007·The Journal of Allergy and Clinical Immunology·Peter J Barnes
May 15, 2007·The Journal of Pharmacology and Experimental Therapeutics·Waldemar GonsiorekR William Hipkin
Feb 2, 2008·Bioorganic & Medicinal Chemistry Letters·Iain Walters David Robinson
Nov 26, 2008·Pharmacology & Therapeutics·R W ChapmanJ S Fine
Jul 1, 2009·Journal of Leukocyte Biology·RoseMarie StillieAndrew W Stadnyk
Aug 1, 2009·The European Respiratory Journal·O HolzH Magnussen
Jun 17, 2010·Respiratory Research·Dave SinghStephen Rennard
Oct 28, 2010·British Journal of Pharmacology·Steven J Charlton, Georges Vauquelin
Dec 24, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R VirtalaL O Cardell
Jun 19, 2012·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P NairUNKNOWN Study Investigators
Aug 28, 2012·The Journal of Clinical Investigation·Thomas JamiesonOwen J Sansom
Sep 22, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Richard B MossUNKNOWN CF2110399 Investigators
May 23, 2014·Science Translational Medicine·Steven L HighfillCrystal L Mackall
Feb 20, 2015·American Journal of Respiratory and Critical Care Medicine·Stephen I RennardHeribert Staudinger

❮ Previous
Next ❯

Citations

May 28, 2016·Nature Reviews. Immunology·Sofia de OliveiraAnna Huttenlocher
Sep 10, 2016·Scandinavian Journal of Gastroenterology·Daniel MuthasMark Berner Hansen
Oct 4, 2017·Angewandte Chemie·Bayard R HuckKlaus Urbahns
Aug 25, 2018·The European Respiratory Journal·Aili L LazaarRuth Tal-Singer
Jun 15, 2017·The Journal of Pharmacology and Experimental Therapeutics·Jakob Busch-PetersenRuth Tal-Singer
May 23, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Philip GardinerKen Grime
Feb 26, 2019·Frontiers in Immunology·Mohib UddinFrauke Pedersen
Oct 5, 2019·Gastroenterology Research and Practice·Caroline Y K FongNaureen Starling
Sep 14, 2018·Frontiers in Oncology·Martin David Forster, Michael-John Devlin
Jun 10, 2017·Journal of Immunology Research·Carina Kärrman MårdhMatthew Thomas
Dec 24, 2018·Therapeutic Advances in Medical Oncology·Kate YoungNaureen Starling
Nov 25, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Bok-Soon LeeChul-Ho Kim
Nov 30, 2020·Cellular Signalling·Dylan Scott EigerSudarshan Rajagopal
Nov 10, 2020·Frontiers in Pharmacology·Chih-Chao ChiangTsong-Long Hwang
Apr 30, 2021·Frontiers in Immunology·Shuvasree SenGuptaCarole A Parent
Apr 6, 2021·British Journal of Pharmacology·Owein Guillemot-Legris, Giulio G Muccioli
May 9, 2021·European Journal of Immunology·Alvaro TeijeiraIgnacio Melero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.